This brand name is authorized in Estonia, Croatia, Ireland, Lithuania, Poland

Active ingredients

The drug OGLUO contains one active pharmaceutical ingredient (API):

1 Glucagon

Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract.

Read about Glucagon

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
OGLUO Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H04AA01 Glucagon H Systemic hormonal preparations, excl. Sex hormones and insulins → H04 Pancreatic hormones → H04A Glycogenolytic hormones → H04AA Glycogenolytic hormones
Discover more medicines within H04AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1841813, 1841824, 1841835, 1841846, 1841857, 1841868, 1841879, 1841880
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1092063, 1092064, 1092065, 1092066, 1092067, 1092068, 1092069, 1092070
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100448499, 100448507, 100448520, 100448536

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.